Home / Health / Canada Approves First Needle-Free Epinephrine Spray
Canada Approves First Needle-Free Epinephrine Spray
16 Apr
Summary
- Health Canada approves Neffy, a needle-free epinephrine nasal spray.
- The spray is for severe allergic reactions in patients 30kg+.
- Neffy offers a new choice alongside EpiPens, with a 30-month shelf life.
Health Canada has given its approval to Neffy, marking the introduction of the country's first needle-free epinephrine treatment for severe allergic reactions. Distributed by ALK Canada, the two-milligram nasal spray is now available for adults and pediatric patients who weigh at least 30 kilograms (approximately 66 lbs).
This innovative spray, which could be on the market as early as summer, offers an alternative to traditional epinephrine auto-injectors, commonly known as EpiPens. Neffy is noted for its pocket-sized design and a shelf life of 30 months from its manufacturing date. Food Allergy Canada has welcomed the approval, recognizing it as a vital advancement that expands treatment options for Canadians.
